GH Research (GHRS) EBITDA (2020 - 2025)

GH Research's EBITDA history runs 6 years deep, the most recent figure standing at -$80.8 million for Q4 2025.

• In Q4 2025, EBITDA fell 623.55% year-over-year to -$80.8 million; the TTM figure through Dec 2025 stood at -$68.0 million (down 65.19% YoY), while the FY2025 annual figure was -$47.6 million, down 15.57% from the prior year.
• EBITDA was -$80.8 million for Q4 2025 at GH Research, down from $14.1 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $14.1 million in Q3 2025 to a low of -$80.8 million in Q4 2025.
• Historically, EBITDA has averaged -$5.4 million across 5 years, with a median of -$5.1 million in 2021.
• The sharpest annual moves came in 2021 and 2022: EBITDA plunged 19066.67% in 2021, then jumped 1482.72% in 2022.
• A 5-year view of EBITDA shows it stood at -$11.8 million in 2021, then surged by 37.3% to -$7.4 million in 2022, then decreased by 1.1% to -$7.5 million in 2023, then sank by 49.75% to -$11.2 million in 2024, then sank by 623.55% to -$80.8 million in 2025.
• The last three EBITDA figures came in at -$80.8 million (Q4 2025), $14.1 million (Q3 2025), and $8.9 million (Q2 2025), per Business Quant data.